Navigation Links
Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians
Date:9/22/2009

khigh.com/allscripts/features.aspx" onclick="linkClick( this.href );" target="_blank" title="Features and Benefits of Allscripts MyWay">key application features and functions necessary for Electronic Health Records (EHR), Practice Management (PM) and Revenue Cycle Management. Allscripts MyWay was designed with the smaller practice in mind, offering a feature-rich, customizable solution that's easy to use at a price point that's affordable and appealing to physicians in the small to medium space.

"Independent physicians and small groups are looking for a way to enter the electronic healthcare highway with affordable costs, minimal IT investment and management requirements, and with a product that is easy to learn. We believe our hosted MyWay electronic health record offering is the right answer at the right time," said Kelley Schudy, Vice President of Channel Sales for Allscripts.

Also available as an on-premise solution, Link High Technologies, a Microsoft Certified partner with an Advanced Infrastructure Competency, can provide the entire infrastructure, as well as procurement and IT management services. With over 17 years in the IT industry and dozens of clients in government, local municipalities, police departments and financial institutions, Link High Technologies has a vast amount of experience in network security and data protection.

"The government has set aside $19 billion in healthcare stimulus incentives to help physicians adopt electronic health records in their practices. With early adoption, physicians will be eligible to receive the full funding of $44,000 to $64,000 in addition to the existing 2% of e-Prescribing and PQRI initiatives," said Victor Liu. The Office of HHS is encouraging early adoption of EHR as full funding will be dispersed over five years beginnin
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Health Robotics Continues Global Expansion Into Oceania With Device Technologies Australias Strategic Partnership
2. Vestara and MedClean Technologies Announce Co-Marketing Partnership to Expand Innovative Solution for Pharmaceutical Waste Management
3. EF Johnson Technologies, Inc. Receives Notice Regarding Minimum Bid Price Rule
4. Health Plans Reduce Administrative Expenses with HEALTHsuite(R) from RAM Technologies, Inc.
5. China Medical Technologies Announces US$30 Million Share Repurchase Program
6. Global Med Technologies, Inc.s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wednesday, September 23, 2009
7. Greenway Medical Technologies PrimeLeader Conference Brings in Record Number of Customers as Company Continues Fast-Paced Growth
8. Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth, Personal Emergency Response and Medical Monitoring Systems
9. Global Med Technologies(R), Inc. Announces Its First EdgeCell Cellular Therapy Software and EdgeLab/HLA Software Sale in North America
10. Palatin Technologies, Inc. Announces PL-3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting
11. HemCon Medical Technologies, Inc. signs exclusive global agreement with Zimmer Dental Inc. to distribute oral surgery dressings
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians
Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians
(Date:12/7/2009)... Chicago have discovered a technique that is able to ... or habitual snoring by screening their urine. , ... relatively simple urine test that could detect OSA in ... and inconvenient sleep studies in children who snore, only ... OSA," said lead author David Gozal, M.D., professor and ...
(Date:12/6/2009)... and SUNNYVALE, Calif., Dec. 6 Pharmacyclics, ... results from a Phase I/II study showing safety ... recurrent non-Hodgkin,s Lymphoma (NHL) treated with its HDAC ... were presented today at the 51st ASH Annual ... # 2726). ,, PCI-24781 is an oral ...
(Date:12/6/2009)... Scientists in Cambridge have discovered that the loss of a ... This is the first study to show that this kind ... today in Nature . , The study, led by ... Matt Hurles from the Wellcome Trust Sanger Institute, looked at ... child,s entire genome looking for types of mutation known as ...
(Date:12/6/2009)... researchers from the Medical College of Wisconsin, in Milwaukee, ... and other sickle cell disease complications in children. Barriers ... and patients were also identified. The study led ... pediatrics at the Medical College and Children,s Research Institute ... at the American Society of Hematology meeting Dec. 7, ...
(Date:12/6/2009)... -- Blood clotting, or coagulation, is an important ... vessel is injured. Sometimes, however, clots form on ... or do not dissolve naturally, a potentially life-threatening ... 51st Annual Meeting of the American Society of ... anticoagulants aspirin and heparin with the hope of ...
Breaking Medicine News(10 mins):Health News:Urine test for pediatric obstructive sleep apnea possible 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 4Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 5Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7
... Crdentia Corp. (OTC Bulletin,Board: CRDT), a leading healthcare ... Jones to Vice President of Operations of Crdentia,s,newly ... immediately. Mr. Jones joins Crdentia from ATS ... allied health staffing services with six offices in,Florida, ...
... -- China Technology,Development Group Corporation (Nasdaq: CTDC; ... energy solutions and network security focusing in ... the appointment of Dr.,Jerry Yan as Chief ... development of the,Company,s strategy, establish an expert ...
... Analysis shows Vermont, Minnesota and Hawaii are nation,s ... Louisiana rank as least-healthy states, WASHINGTON, Nov. ... over the past year, despite progress made in ... today by United Health,Foundation, the American Public Health ...
... Increase Nearly 17 Percent; Ambulatory Surgical ... Centers Increase 364 ... ENDO ), an innovative medical device company focused on the,development ... tissue and tumor ablation, announced today,that the federal Centers for ...
... SAN DIEGO, Nov. 5 ADVENTRX Pharmaceuticals,Inc. (Amex: ... company,focused on commercializing proprietary product candidates for the ... Brian M. Culley,ADVENTRX,s chief business officer, is scheduled ... on November 14th, 2007 at 11:30,a.m. Central European ...
... HAVEN, Conn., Nov. 5 ,Following consultation with the ... the U.S. Food and Drug Administration (FDA),Health Canada, ... it,has elected to temporarily suspend worldwide marketing of ... BART trial can,be compiled, received and evaluated. The ...
Other Medicine News:Health News:Crdentia Announces Appointment of Tim Jones to Senior Management Team 2Health News:Crdentia Announces Appointment of Tim Jones to Senior Management Team 3Health News:CTDC Appoints Chief Scientist 2Health News:CTDC Appoints Chief Scientist 3Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 2Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 3Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 4Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 5Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 6Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 7Health News:Medicare Increases 2008 Hospital Reimbursement Rates for Cryoablation Treatments of Prostate Cancer 2Health News:Medicare Increases 2008 Hospital Reimbursement Rates for Cryoablation Treatments of Prostate Cancer 3Health News:ADVENTRX Pharmaceuticals to Present at the 13th Annual BIO-Europe Partnering Conference 2Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 2Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 3Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 4
(Date:12/4/2009)... Imaging, LLC, an independent provider of CT, MRI ... and healthcare providers, is excited to announce it ... Health Care, a nationally-recognized, prestigious gold seal of ... Shared Imaging accreditation is system-wide for its mobile ...
(Date:12/4/2009)... Ill., Dec. 4 Hospira, Inc. (NYSE: ... delivery company, today announced the launch of its next-generation ... (I.V.) medications and solutions, and now offers a complete ... award-winning, environmentally responsible VisIV product. The launch of the ...
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, today ... and Chief Financial Officer. In this role, Mr. ... functions including finance, accounting, IT, IR, administration and human ... senior management team. ,, "One of my key ...
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Toms of Maine Invites Public Participation in 50 States for Good Program 48207 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 2More Ontario children are getting diagnosed with diabetes 3A ICES study 48205 1Common chemotherapy drug triggers fatal allergic reactions 8748 1Common chemotherapy drug triggers fatal allergic reactions 8748 2Common chemotherapy drug triggers fatal allergic reactions 8748 3
... NEW YORK, June 30 In the fall of ... receive music from artists they,love and artists they will discover ... model will create a new revenue stream for artists,and labels ... Don MacKinnon, founder of HEAR Music and former Vice ...
... Increase in Mature Dendritic Cells -, WAYNE, ... that results of a Phase II trial were,published ... of Clinical Oncology. The,study showed that Leukine(R) (sargramostim) ... increased mature dendritic cells in high-risk,melanoma patients. Dendritic ...
Other Medicine Technology:(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa 2(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa 3Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 2Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 3Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 4Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 5
Provides quick freezing and quick defrosting. Lightweight probe tips have high conductivity silver. Useful for Cataract, Retinal Detachment, Glaucoma and Intra-vitreal surgery. Includes either one ca...
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Manual Table For Slit Lamp...
Medicine Products: